Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Lysosphingolipids in ceramide-deficient skin lipid models

G. Paraskevopoulos, L. Opálka, A. Kováčik, A. Paraskevopoulou, E. Panoutsopoulou, I. Sagrafena, P. Pullmannová, R. Čáp, K. Vávrová

. 2025 ; 66 (1) : 100722. [pub] 20241207

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25010446

Ceramides are key components of the skin's permeability barrier. In atopic dermatitis, pathological hydrolysis of ceramide precursors - glucosylceramides and sphingomyelin - into lysosphingolipids, specifically glucosylsphingosine (GS) and sphingosine-phosphorylcholine (SPC), and free fatty acids (FFAs) has been proposed to contribute to impaired skin barrier function. This study investigated whether replacing ceramides with lysosphingolipids and FFAs in skin lipid barrier models would exacerbate barrier dysfunction. When applied topically to human stratum corneum sheets, SPC and GS increased water loss, decreased electrical impedance, and slightly disordered lipid chains. In lipid models containing isolated human stratum corneum ceramides, reducing ceramides by ≥ 30% significantly increased permeability to four markers, likely due to loss of long-periodicity phase (LPP) lamellae and phase separation within the lipid matrix, as revealed by X-ray diffraction and infrared spectroscopy. However, when the missing ceramides were replaced by lysosphingolipids and FFAs, no further increase in permeability was observed. Conversely, these molecules partially mitigated the negative effects of ceramide deficiency, particularly with 5%-10% SPC, which reduced permeability even compared to control with "healthy" lipid composition. These findings suggest that while ceramide deficiency is a key factor in skin barrier dysfunction, the presence of lysosphingolipids and FFAs does not aggravate lipid structural or functional damage, but may provide partial compensation, raising further questions about the behavior of lyso(sphingo)lipids in rigid multilamellar lipid environments, such as the stratum corneum, that warrant further investigation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010446
003      
CZ-PrNML
005      
20250429134710.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jlr.2024.100722 $2 doi
035    __
$a (PubMed)39653083
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Paraskevopoulos, Georgios $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic
245    10
$a Lysosphingolipids in ceramide-deficient skin lipid models / $c G. Paraskevopoulos, L. Opálka, A. Kováčik, A. Paraskevopoulou, E. Panoutsopoulou, I. Sagrafena, P. Pullmannová, R. Čáp, K. Vávrová
520    9_
$a Ceramides are key components of the skin's permeability barrier. In atopic dermatitis, pathological hydrolysis of ceramide precursors - glucosylceramides and sphingomyelin - into lysosphingolipids, specifically glucosylsphingosine (GS) and sphingosine-phosphorylcholine (SPC), and free fatty acids (FFAs) has been proposed to contribute to impaired skin barrier function. This study investigated whether replacing ceramides with lysosphingolipids and FFAs in skin lipid barrier models would exacerbate barrier dysfunction. When applied topically to human stratum corneum sheets, SPC and GS increased water loss, decreased electrical impedance, and slightly disordered lipid chains. In lipid models containing isolated human stratum corneum ceramides, reducing ceramides by ≥ 30% significantly increased permeability to four markers, likely due to loss of long-periodicity phase (LPP) lamellae and phase separation within the lipid matrix, as revealed by X-ray diffraction and infrared spectroscopy. However, when the missing ceramides were replaced by lysosphingolipids and FFAs, no further increase in permeability was observed. Conversely, these molecules partially mitigated the negative effects of ceramide deficiency, particularly with 5%-10% SPC, which reduced permeability even compared to control with "healthy" lipid composition. These findings suggest that while ceramide deficiency is a key factor in skin barrier dysfunction, the presence of lysosphingolipids and FFAs does not aggravate lipid structural or functional damage, but may provide partial compensation, raising further questions about the behavior of lyso(sphingo)lipids in rigid multilamellar lipid environments, such as the stratum corneum, that warrant further investigation.
650    _2
$a lidé $7 D006801
650    12
$a ceramidy $x metabolismus $7 D002518
650    12
$a kůže $x metabolismus $7 D012867
650    _2
$a sfingosin $x analogy a deriváty $x metabolismus $7 D013110
650    _2
$a kyseliny mastné neesterifikované $x metabolismus $7 D005230
650    _2
$a permeabilita $x účinky léků $7 D010539
650    _2
$a lysofosfolipidy $x metabolismus $7 D008246
650    _2
$a biologické modely $7 D008954
650    _2
$a fosforylcholin $x analogy a deriváty $7 D010767
655    _2
$a časopisecké články $7 D016428
700    1_
$a Opálka, Lukáš $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Kováčik, Andrej $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Paraskevopoulou, Anna $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Panoutsopoulou, Eleni $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Sagrafena, Irene $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Pullmannová, Petra $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Čáp, Robert $u Plastic Surgery Clinic, Sanatorium Sanus, Hradec Králové, Czech Republic
700    1_
$a Vávrová, Kateřina $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic. Electronic address: katerina.vavrova@faf.cuni.cz
773    0_
$w MED00002766 $t Journal of lipid research $x 1539-7262 $g Roč. 66, č. 1 (2025), s. 100722
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39653083 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134705 $b ABA008
999    __
$a ok $b bmc $g 2311665 $s 1247527
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 66 $c 1 $d 100722 $e 20241207 $i 1539-7262 $m Journal of lipid research $n J Lipid Res $x MED00002766
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...